missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Apolipoprotein M Monoclonal Antibody (8F12C6B8), Invitrogen™
Mouse Monoclonal Antibody
Marque: Invitrogen MA515322
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
MA5-15322 targets ApoM in indirect ELISA, IF and WB applications and shows reactivity with Human samples. The MA5-15322 immunogen is purified recombinant fragment of human ApoM expressed in E. Coli. MA5-15322 detects ApoM which has a predicted molecular weight of approximately 21kDa.
The protein encoded by this gene is an apolipoprotein and member of the lipocalin protein family. It is found associated with high density lipoproteins and to a lesser extent with low density lipoproteins and triglyceride-rich lipoproteins. The encoded protein is secreted through the plasma membrane but remains membrane-bound, where it is involved in lipid transport. Two transcript variants encoding two different isoforms have been found for this gene, but only one of them has been fully characterized.
Spécification
| Apolipoprotein M | |
| Monoclonal | |
| 1.0 mg/mL | |
| PBS with 0.03% sodium azide | |
| O95445 | |
| APOM | |
| Purified recombinant fragment of human ApoM expressed in E. Coli. | |
| 100 μg | |
| Primary | |
| Human, Non-human Primate | |
| Antibody | |
| IgG1 |
| ELISA, Immunocytochemistry, Western Blot | |
| 8F12C6B8 | |
| Unconjugated | |
| APOM | |
| 1190010O19Rik; alternative name: G3a, NG20; Apo M; Apolipoprotein M; APOM; apo-M; G3A; HSPC336; MGC22400; NG20; NG20 like protein; NG20-like protein; protein G3a; Protein Px | |
| Mouse | |
| Protein G | |
| RUO | |
| 55937 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Apolipoprotein M Monoclonal Antibody (8F12C6B8), Invitrogen™ > 100 μg; Unconjugated
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu
